Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Pharma, Inc. | 916,674 | reported | 11 Aug 2025 | tx 66+1,940,015−1,942,871 |
| GERON CORP | 120,251 | reported | 11 May 2011 | tx 21+190,251−57,500 |
| Population Health Investment Co., Inc. | 43,125 | reported | 26 Jan 2021 | tx 1+43,125 |
| Maze Therapeutics, Inc. | 31,113 | reported | 04 May 2026 | tx 19+260,763−527,943 |
| Global Blood Therapeutics, Inc. | 15,000 | reported | 20 Jun 2018 | tx 39+229,661−311,155 |
| CYTOKINETICS INC | 15,000 | reported | 22 May 2008 | tx 4+40,000 |
| PLIANT THERAPEUTICS, INC. | 13,286 | reported | 29 Jun 2021 | tx 1+13,286 |
| PORTOLA PHARMACEUTICALS INC | 10,000 | reported | 28 Mar 2019 | tx 64+766,592−1,366,541 |
| KOSAN BIOSCIENCES INC | 6,000 | reported | 25 May 2007 | tx 3+18,000 |
| MILLENNIUM PHARMACEUTICALS INC | 0 | reported | 14 May 2008 | tx 66+317,673−1,064,942 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | GIFT | Maze Therapeutics, Inc. | 7,422 | 0.00 USD | |
| 19 Nov 2025 | OTHER | Maze Therapeutics, Inc. | 1,489 | 0.00 USD | |
| 23 Oct 2025 | GIFT | Maze Therapeutics, Inc. | 28,423 | 0.00 USD | |
| 22 Sept 2025 | GRANT_AWARD | Maze Therapeutics, Inc. | 18,000 | 0.00 USD | deriv |
| 08 Aug 2025 | SALE | BridgeBio Pharma, Inc. | 58,338 | 46.64 USD | |
| 08 Aug 2025 | SALE | BridgeBio Pharma, Inc. | 191,662 | 45.87 USD | |
| 11 Aug 2025 | SALE | BridgeBio Pharma, Inc. | 50,000 | 48.00 USD | |
| 27 Jun 2025 | GIFT | BridgeBio Pharma, Inc. | 20,000 | 0.00 USD | |
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 6,589 | 0.00 USD | |
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 8,425 | 0.00 USD | deriv |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 7,422 | — | |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 20,717 | — | |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 8,807 | — | |
| 09 Dec 2024 | GRANT_AWARD | Maze Therapeutics, Inc. | 5,704 | 0.00 USD | deriv |
| 09 Dec 2024 | OTHER | Maze Therapeutics, Inc. | 46,675 | — | deriv |
| 09 Dec 2024 | OTHER | Maze Therapeutics, Inc. | 5,704 | — | deriv |
| 09 Dec 2024 | GRANT_AWARD | Maze Therapeutics, Inc. | 80,385 | 0.00 USD | deriv |
| 26 Nov 2024 | CONVERSION | Maze Therapeutics, Inc. | 80,385 | 78961.64 USD | deriv |
| 26 Nov 2024 | CONVERSION | Maze Therapeutics, Inc. | 71,564 | — | deriv |
| 09 Dec 2024 | GRANT_AWARD | Maze Therapeutics, Inc. | 46,675 | 0.00 USD | deriv |
| 09 Dec 2024 | OTHER | Maze Therapeutics, Inc. | 45,638 | — | deriv |
| 09 Dec 2024 | GRANT_AWARD | Maze Therapeutics, Inc. | — | 0.00 USD | deriv |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 72,727 | — | deriv |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 169,405 | — | deriv |
| 03 Feb 2025 | CONVERSION | Maze Therapeutics, Inc. | 71,564 | — | deriv |